Induction chemotherapy before surgery for unresectable head and neck cancer.

Date publication

janvier 2016

Journal

B-ENT

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOREL Christian , Pr DEBRY Christian

Tous les auteurs :
Schmaltz H, Borel C, Ciftci S, Takeda-Raguin C, Debry C, Schultz P, Dupret-Bories A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27097391

Résumé

To preoperatively reduce tumour size in patients with locally advanced and/or non-resectable squamous cell carcinoma with induction chemotherapy in order to achieve surgical excision with clear margins and preserve quality of life.

Mots clés

Adult, Antineoplastic Combined Chemotherapy Protocols, administration & dosage, Carboplatin, administration & dosage, Carcinoma, Squamous Cell, drug therapy, Cetuximab, administration & dosage, Cisplatin, administration & dosage, Cohort Studies, Disease-Free Survival, Female, Fluorouracil, administration & dosage, Head and Neck Neoplasms, drug therapy, Humans, Induction Chemotherapy, methods, Male, Middle Aged, Mouth Neoplasms, drug therapy, Oropharyngeal Neoplasms, drug therapy, Paclitaxel, administration & dosage, Retrospective Studies, Taxoids, administration & dosage, Treatment Outcome

Référence

B-ENT. 2016 ;12(1):29-32